Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03890029 · ClinicalTrials.gov registry record · NA

G.R.I.T. - Goal-directed Resilience Intervention Training

A NA study, sponsored by Morehouse School of Medicine.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT03890029: Completed NA study, sponsored by Morehouse School of Medicine.

NCT03890029 is a NA study that has completed, run by Morehouse School of Medicine. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03890029, a NA study, has completed, sponsored by Morehouse School of Medicine.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

This research program has addressed three reactive adaptations evident in pain, PTSD, and obesity. In this project, the focus will be on PTSD as a model of stimulus-based reactive responses to unpredictability or threat, and the investigators propose to test the efficacy of the goal-directed skills training (GRIT) program for restoring predictive responding and homeostasis. The challenge of how best to cultivate psychological resilience in the face of stress, trauma, and social adversity among disadvantaged populations is a complex question best answered with a translational research approach. This research' intent is to help African American women who are dealing with stress after traumatic experiences. It will specifically study Post-traumatic Stress Disorder, a disorder that affects people who have experienced severe traumas. It is associated with a number of overwhelming emotional symptoms. These include sleep difficulties, depression and anxiety, flashbacks and nightmares of the traumatic events. The training is an 8-week skill building program that helps people use positive experiences from their past to cope with current difficulties. The investigators will collect blood samples for future research to understand how the body's stress response changes as a result of this training

Primary Outcome

Changes in pre-to-post scores among intervention versus control group as measured by the Clinician Administered PTSD Scale for DSM 5 (CAPS-5): clinician-administered, structured interview ideal for screening, differential diagnosis \& confirmation of PTSD. Each item is scored on a scale of 0-4; the total composite score range is 0-212; Lower score = better outcome

Interventions

  • BEHAVIORAL Control Condition
  • BEHAVIORAL Intervention Training

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2021-07-13
Est. Completion 2023-03-07
Phase NA
Morehouse School of Medicine

13 total trials

What the finished NCT03890029 record still lists

NCT03890029 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Control Condition is the first listed.

NCT03890029 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03890029 about?

NCT03890029 is a clinical study titled "G.R.I.T. - Goal-directed Resilience Intervention Training". This research program has addressed three reactive adaptations evident in pain, PTSD, and obesity. In this project, the focus will be on PTSD as a model of stimulus-based reactive responses to unpredictability or threat, and the investigators propose to test the efficacy of the goal-directed skills ...

What is the current status of trial NCT03890029?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2021-07-13. Estimated completion is 2023-03-07.

What interventions are being tested in trial NCT03890029?

The interventions under investigation include: Control Condition (BEHAVIORAL), Intervention Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03890029?

This trial is sponsored by Morehouse School of Medicine, which has 13 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03890029's enrollment target sits among peer trials

38 1538th of 2000 higher than 461 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03890029, the US trial registry maintained by the National Library of Medicine. NCT03890029 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.